You are here
Medicinal cannabis manufacture
Technical guidance on the interpretation of the PIC/S Guide to GMP
Complaints and product recall (Chapter 8, Part I - finished dosage form)
Clauses 8.7 and 8.8 of the PIC/S Guide to GMP require that the procedures on complaints handling should include an assessment for counterfeit products. If counterfeiting is detected the TGA must be notified in accordance with the Uniform Recall Procedure for Therapeutic Goods (URPTG).